Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochromes P450

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1327-1334

  Zhao, Xue Jun ^a   Yokoyama, Hiroyuki ^a   Chiba, Kan ^a   Wanwimolruk, Sompon ^b   Ishizaki, Takashi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450; DESIPRAMINE; DICLOFENAC; KETOCONAZOLE; OXYGENASE; PHENACETIN; QUININE; TESTOSTERONE; TROLEANDOMYCIN;

ARTICLE; CATALYSIS; DRUG HYDROXYLATION; DRUG INHIBITION; DRUG METABOLISM; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL;

ANTIBODIES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; HYDROXYLATION; ISOENZYMES; MICROSOMES, LIVER; QUININE; RECOMBINANT PROTEINS;

EID: 0030438696     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BROCKMÖLLER, J. AND ROOTS, I.: Assessment of liver metabolic function: Clinical implications. Clin. Pharmacokinet. 27: 216-248, 1994.
2. CHIBA, K., KOBAYASHI, K., MANABE, K., TANI, M., KAMATAKI, T. AND ISHIZAKI, T.: Oxidative metabolism of omeprazole in human liver microsomes: Cosegregation with S-mephenytoin 4′-hydroxylation. J. Pharmacol. Exp. Ther. 266: 52-59, 1993a.
3. MP) activity in human liver samples obtained as surgical waste from Japanese patients. Drug Metab. Dispos. 21: 747-749, 1993b.
4. CHIBA, K., MANABE, K., KOBAYASHI, K., TAKAYAMA, Y., TANI, M. AND ISHIZAKI, T.: Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes. Eur. J. Clin. Pharmacol. 44: 559-562, 1993c.
5. CHIBA, K., SAITOH, A., KOYAMA, E., TANI, M., HAYASHI, M. AND ISHIZAKI, T.: The role of S-mephenytoin 4′-hydroxylase in imipramine metabolism by human liver microsomes: A two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation. Br. J. Clin. Pharmacol. 37: 237-242, 1994.
6. dE MORAIS, S. M. E., WILKINSON, G. R., BLAISDELL, J., NAKAMURA, K., MEYER, U. A. AND GOLDSTEIN, J. A.: The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol. Chem. 269: 15419-15422, 1994.
7. ECHIZEN, H., KAWASAKI, H., CHIBA, K., TANI, M. AND ISHIZAKI, T.: A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. J. Pharmacol. Exp. Ther. 264: 1425-1431, 1993.
8. GLUE, P. AND BANFIELD, C.: Psychiatry, psychopharmacology and P-450s. Hum. Psychopharmacol. 11: 97-114, 1996.
9. GOLDSTEIN, J. A. AND DE MORAIS, S. M. E.: Biochemical and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4: 285-299, 1994.
10. GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., WOLFF, T. AND WAXMAN, D. J.: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidation drug metabolism. J. Biol. Chem. 261: 5051-5060, 1986a.
11. GUENGERICH, F. P., MULLER-ENOCH, D. AND BLAIR, I. A.: Oxidation of quinidine by human liver cytochrome P-450. Mol. Pharmacol. 30: 287-295, 1986b.
12. GUENGERICH, F. P. AND SHIMADA, T.: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4: 391-407, 1991.
13. KAMINSKY, L. S., FASCO, M. J. AND GUENGERICH, F. P.: Production and application of antibodies to rat liver cytochrome P-450. Methods Enzymol. 74: 262-272, 1981.
14. KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. AND MEYER, U. A.: High-performance liquid chromatographic assay for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Anal. Biochem. 162: 24-32, 1986.
15. LEEMANN, T., TRANSON, C. AND DAYER, P.: Cytochrome P450TB (CYP2C): A major monoxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci. 52: 29-34, 1992.
16. LIDDLE, C., GRAHAM, G. G., CHRISTOPHER, P. K., BHUWAPATHANAPUM, S. AND DUFFIELD, A. M.: Identification of new urinary metabolites in man of quinine using methane chemical ionization gas chromatography-mass spectrometry. Xenobiotica 11: 81-87, 1981.
17. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. MAURICE, M., PICHARD, L., DAUJAT, M., FABRE, I., JOYEUX, H., DOMERGUE, J. AND MAUREL, P.: Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB. J. 6: 752-758, 1992.
19. NEWTON, D. J., WANG, R. W. AND LU, A. Y. H.: Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23: 154-158, 1995.
20. PANISKO, D. M. AND KEYSTONE, J. S.: Treatment of malaria - 1990. Drugs 39: 160-189, 1990.
21. SHIMADA, T., MISONO, K. AND GUENGERICH, F. P.: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261: 909-921, 1986.
22. SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. AND GUENGERICH, F. P.: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270: 414-423, 1994.
23. TASSANEEYAKUL, W., BIRKETT, D. J., VERONESE, M. E., MCMANUS, M. E., TUKEY, R. H., QUATTROCHI, L. C., GELBOIN, H. V. AND MINERS, J. O.: Specificity of substrate and inhibitor probes for human cytochrome P4501A1 and 1A2. J. Pharmacol. Exp. Ther. 265: 401-407, 1993.
24. TRACY, J. W. AND WEBSTER, L. T.: Drugs used in the chemotherapy of protozoal infections: Malaria. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. G. Gilman, pp. 965-985, McGraw-Hill, New York, 1996.
25. WANWIMOLRUK, S., WONG, S. M., COVILLE, P. F. AND WALKER, R. J.: In vitro hepatic microsomal metabolism of quinine: Identification of P450 enzymes responsible for quinine metabolism. Can. J. Physiol. Pharmacol. 72 (suppl. 1): 294, 1994.
26. WANWIMOLRUK, S., WONG, S. M., ZHANG, H. AND COVILLE, P. F.: Simultaneous determination of quinine and a major metabolite, 3-hydroxyquinine, in biological fluids by HPLC without extraction. J. Liquid Chromatogr. 19: 293-305, 1996.
27. WANWIMOLRUK, S., WONG, S. M., ZHANG, H., COVILLE, P. F. AND WALKER, R. J.: Metabolism of quinine in man: Identification of a major metabolite, and effects of smoking and rifampicin pretreatment. J. Pharm. Pharmacol. 47: 957-963, 1995.
28. WATKINS, P. B.: Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin. North Am. 21: 511-526, 1992.
29. WATKINS, P. B.: Noninvasive tests of CYP3A enzymes. Pharmacogenetics 4: 171-184, 1994.
30. WATKINS, P. B., WRIGHTON, S. A., MAUREL, J. P., SCHUETZ, E. G., MENDEZ-PICON, G., PARKER, G. A. AND GUZELIAN, P. S.: Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. U.S.A. 82: 6310-6314, 1985.
31. WAXMAN, D. J., ATTISANO, C., GUENGERICH, F. P. AND LAPENSON, D. P.: Human liver microsomal steroid metabolism: Identification of the major steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch. Biochem. Biophys. 263: 424-136, 1988.
32. WHITE, N. J.: Drug treatment and prevention of malaria. Eur. J. Clin. Pharmacol. 34: 1-14, 1988.
33. WHITE, N. J.: Antimalarial pharmacokinetics and treatment regimens. Br. J. Clin. Pharmacol. 34: 1-10, 1992.
34. WHITE, N. J., LOOAREESUWAN, S., WARRELL, D. A., WARRELL, M. J., BUNNAG, D. AND HARINASUTA, T.: Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am. J. Med. 73: 564-572, 1982.
35. WHITE, N. J., LOOAREESUWAN, S., WARRELL, D. A., WARRELL, M. J., CHANTHAVANICH, P., BUNNAG, D. AND HARINASUTA, T.: Quinine loading dose in cerebral malaria. Am. J. Trop. Med. Hyg. 32: 1-5, 1983.
36. WRIGHTON, S. A. AND STEVENS, J. C.: The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22: 1-21, 1992.
37. WRIGHTON, S. A., STEVENS, J. C., BACKER, G. W. AND VANDENBRANDES, M.: Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch. Biochem. Biophys. 306: 240-245, 1993.
38. YASUMORI, T., MURAYAMA, N., YAMAZOE, Y. AND KATO, R.: Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clin. Pharmacol. Ther. 47: 313-322, 1990.
39. YOSHIMOTO, K., ECHIZEN, H., CHIBA, K., TANI, M. AND ISHIZAKI, T.: Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-Desisopropylation is mediated mainly by CYP1A2. Br. J. Clin. Pharmacol. 39: 421-431, 1995.